Transcatheter Aortic Valve Replacement in Patients With Reduced Ejection Fraction and Nonsevere Aortic Stenosis.

"Disclosures Dr Ludwig was supported by grant from the German Heart Foundation (DHS), has received speaker honoraria from Abbott, travel compensation from Edwards Lifesciences and advisory fees from Bayer. Dr Schofer has received speaking honoraria and proctor fees from Edwards Lifesciences. Dr Renker received speaker fees from St. Jude Medical and Abbott. Dr Hamm receives honoraria from Astra-Zeneca, Sanofi, and Lilly and research funding from AstraZeneca and TMC. Dr Coisne is proctor for Abbott Vascular and speaker for Abbot Vascular and GE Healthcare Dr Kim received personal fees from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, Meril Life Sciences, Shockwave Med. Dr Clavel has received funding from Edwards Lifesciences and Medtronic for computed tomography core laboratory analyses and research studies in the field of surgical bioprostheses. The other authors report no conflicts."

"Sources of Funding This study was supported by a grant from the German Heart Foundation (DHS)."

"Registration:: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04914481."